The Board has determined that the appellant's bladder cancer is as likely as not due to Agent Orange exposure in service, and thus grants service connection for residuals of a radical cystoprostatectomy with construction of a permanent ileal conduit for cancer of the bladder. However, there is no competent medical evidence showing prostate cancer, so service connection for prostate cancer secondary to Agent Orange exposure cannot be granted.
The deciding factor: The Board found that the appellant's bladder cancer was as likely as not due to Agent Orange exposure in service and thus grants service connection for residuals of a radical cystoprostatectomy with construction of a permanent ileal conduit for cancer of the bladder. The claim for prostate cancer secondary to Agent Orange exposure cannot be granted because there is no competent medical evidence showing prostate cancer.
- Claimed conditions
- Prostate cancer, Bladder cancer
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- November 1, 2000
- Citation
- 0028884
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0028884.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board has denied service connection for bladder cancer, gastroesophageal reflux disease (GERD), and chronic obstructive pulmonary disease (COPD) as there is no evidence to support a link between these conditions and the Veteran's military service.
- Granted
The Veteran's arteriosclerotic heart disease is rated at 100% effective October 25, 2024. His prostate cancer residuals are rated at 60% effective October 25, 2024.
- Remanded (sent back)
The Board has remanded the claims for bladder cancer, erectile dysfunction, and gouty arthropathy due to outstanding VA treatment records not being obtained. The Veteran's request for a referral to a urologist for ED is also remanded. A VA medical opinion is needed regarding the relationship between the Veteran's gouty arthropathy and his service-connected conditions.
- Dismissed
The Veteran's claims for service connection for bladder and kidney cancer were dismissed as the Notice of Disagreement was not filed within one year of the denial.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.